Vietnam’s real estate M&A market is bouncing back strongly this year after a long, quiet spell. With legal hurdles cleared, global capital flowing in, and major corporate shake-ups happening, the stage is set for a surge of big deals.

The entry of foreign strategic investors with strong financial capacity and technological advantages has helped Vietnamese pharmaceutical companies significantly enhance their competitiveness and expand export markets.

The Vietnamese pharmaceutical sector has recently witnessed one of its largest mergers and acquisitions (M&A) to date, with Livzon Pharmaceutical Group Inc. of China acquiring approximately 64.81% of Imexpharm Pharmaceutical Joint Stock Company (IMP).